Xynomic Pharmaceuticals Holdings, INC.
SEC CIK 1697805 · XYN · last insider filing 2019-05-30
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Qian Tingzhi | Director | filed 2019 - 2019 |
| Xu Yinglin Mark | Director · Chmn, CEO, Pres and Int CFO | filed 2019 - 2019 |
| Xu Peixin | Director · President | filed 2017 - 2019 |
| Wu Peidong | Director | filed 2018 - 2018 |
| Tong James Jiayuan | Director · CEO and CFO | filed 2017 - 2017 |
| Prizzi Charles Vincent | Director | filed 2017 - 2017 |
| Folinsbee Thomas | Director | filed 2017 - 2017 |
| Wang Ning | Director | filed 2017 - 2017 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Wu Wentao Jason | Chief Operating Officer | filed 2019 - 2019 |
| Kou Jinwei Coco | Interim Chief Acc. Officer | filed 2019 - 2019 |
| Bu Fan | CFO & Principal Acct. Officer | filed 2017 - 2017 |
| Jin Peng | COO & Secretary | filed 2017 - 2017 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.